Therefore, a One Health approach is required to understand the wider impact of community antibiotic use and improve overall effectiveness of intervention policy and regulatory action.Ĭhloramphenicol is a phenicol class antibiotic with a narrow margin of safety used in small animal and human medicine. By limiting the health sector scope of antimicrobial resistance research to either human or animal antibiotic use, results can falsely inform policy and intervention strategies. Human consumption of chloramphenicol residues through local animal products represents a serious public health concern. Specifically, chloramphenicol products licensed for human use were being administered to Ugandan poultry. Focus group participants reported that farmers used human-intended antibiotics for their livestock, and community members obtain animal-intended antibiotics for their own personal human use. Focus group discussions with drug shop vendors were also employed to explore antibiotic use practices in the community.

This study collected data on the antibiotics stocked in human (42) and veterinary (21) drug shops in five sub-counties in Luwero district of Uganda. Policy decisions to mitigate the development of antimicrobial resistance are hampered by the current lack of surveillance data on antibiotic product availability and use in low-income countries. Since the introduction of antibiotics into mainstream health care, resistance to these drugs has become a widespread issue that continues to increase worldwide.

Crossover health campaigns